Solventum (SOLV)Director bought ~$100K
Amy Mcbride Wendell, Director at Solventum, bought ~$100K of Solventum shares.
- ~$100K
- Approx. value · 1,475 sh @ $68.03
- 5,039
- Holds after · shares reported
- Traded
- Mar 10, 2026
- Filed
- Mar 11, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 31, 2025CongressDisclosed sale of SOLV — reported range $15,001 - $50,000
- Jan 27, 20265% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 8.8%
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 10, 2026 · this disclosureInsider · 10 days before an 8-KDirector purchased ~$100K of SOLV shares in the open market
What came next
- Mar 13, 2026FDAFDA device clearance: Promogran Prisma Collagen Matrix with ORC and Silver
- Mar 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.”
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.3%
- May 5, 2026Company filing · Form 8-K · ResultsReported its results
- May 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026.”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Solventum
For Solventum, OQRO holds 2 Congress trade reports and 4 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOLV page.
Other recent filings by Amy Mcbride Wendell, Director
The full history of Amy Mcbride Wendell, Director is on the profile page.
How this filing works
Other disclosures at Solventum
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRAug 7, 2026
- SEC Form 13F-HRAug 6, 2026
- Senate eFD periodic transaction reportAug 5, 2026
- Senate eFD periodic transaction reportJul 21, 2026
Everything OQRO holds on this company is on its SOLV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
